Award recordCONTRACT

ABBOTT LABORATORIES INC.

PIID VA25817J2987· VHA· 258-NETWORK CNTRCT OFF 22G (36C258)· 6505 · DRUGS AND BIOLOGICALS· FY2018· $6,714,011 net obligations· UEI NH3LDK8CFAK7· IL

Description

COST PER TEST REAGENTS

Base award description: COST PER TEST

First action · last action
2017-10-01 · 2021-08-16
Transactions
13
First transaction's obligation
$0
Base + all options value (sum of deltas)
$12,875,687
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P7335A
NAICS
334516 · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING

Modification chain · 13 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$7,390,518$0Base award · 2017-10-01 · this action $0 · running total $0Modification P00001 · 2017-10-01 · this action $2,044,089 · running total $2,044,089Modification P00002 · 2018-08-30 · this action $0 · running total $2,044,089Modification P00003 · 2018-10-01 · this action $2,044,089 · running total $4,088,178Modification P00004 · 2019-09-24 · this action $270,000 · running total $4,358,178Modification P00006 · 2019-10-01 · this action $2,044,089 · running total $6,402,267Modification P00007 · 2019-10-29 · this action -$29,409 · running total $6,372,858Modification P00008 · 2020-04-14 · this action -$4,384 · running total $6,368,473Modification P00009 · 2020-09-21 · this action $0 · running total $6,368,473Modification P00010 · 2020-10-01 · this action $1,022,045 · running total $7,390,518Modification P00011 · 2021-03-08 · this action $0 · running total $7,390,518Modification P00012 · 2021-06-24 · this action -$566,179 · running total $6,824,339Modification P00013 · 2021-08-16 · this action -$110,328 · running total $6,714,011
  • Base2017-10-01+$0= $0
  • Mod P000012017-10-01+$2,044,089= $2,044,089
  • Mod P000022018-08-30+$0= $2,044,089
  • Mod P000032018-10-01+$2,044,089= $4,088,178
  • Mod P000042019-09-24+$270,000= $4,358,178
  • Mod P000062019-10-01+$2,044,089= $6,402,267
  • Mod P000072019-10-29-$29,409= $6,372,858
  • Mod P000082020-04-14-$4,384= $6,368,473
  • Mod P000092020-09-21+$0= $6,368,473
  • Mod P000102020-10-01+$1,022,045= $7,390,518
  • Mod P000112021-03-08+$0= $7,390,518
  • Mod P000122021-06-24-$566,179= $6,824,339
  • Mod P000132021-08-16-$110,328= $6,714,011
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2017-10-01+$0$0COST PER TEST
Mod P00001· FUNDING ONLY ACTION2017-10-01+$2,044,089$2,044,089COST PER TEST REAGENTS
Mod P00002· EXERCISE AN OPTION2018-08-30+$0$2,044,089COST PER TEST REAGENTS
Mod P00003· EXERCISE AN OPTION2018-10-01+$2,044,089$4,088,178COST PER TEST REAGENTS
Mod P00004· FUNDING ONLY ACTION2019-09-24+$270,000$4,358,178COST PER TEST REAGENTS. MOD INCREASE $270,000.00
Mod P00006· EXERCISE AN OPTION2019-10-01+$2,044,089$6,402,267COST PER TEST REAGENTS
Mod P00007· FUNDING ONLY ACTION2019-10-29−$29,409$6,372,858COST PER TEST REAGENTS
Mod P00008· FUNDING ONLY ACTION2020-04-14−$4,384$6,368,473COST PER TEST REAGENTS
Mod P00009· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2020-09-21+$0$6,368,473COST PER TEST REAGENTS
Mod P00010· EXERCISE AN OPTION2020-10-01+$1,022,045$7,390,518COST PER TEST REAGENTS
Mod P00011· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2021-03-08+$0$7,390,518COST PER TEST REAGENTS
Mod P00012· FUNDING ONLY ACTION2021-06-24−$566,179$6,824,339COST PER TEST REAGENTS
Mod P00013· FUNDING ONLY ACTION2021-08-16−$110,328$6,714,011COST PER TEST REAGENTS

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI NH3LDK8CFAK7)

AwardOffice · PSC / listingNet obligationsFY
36C24426N1004244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$187,594FY2026
36C24426N1005244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$395,322FY2026
36C24426N1001244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$431,969FY2026
36C24426N1003244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$267,954FY2026
36C24426N1002244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$607,544FY2026
36C24426N1006244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$783,641FY2026

Other recipients under 6505 from 258-NETWORK CNTRCT OFF 22G (36C258) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C25821P0342MCKESSON CORPORATION258-NETWORK CNTRCT OFF 22G (36C258)$750FY2021
36C25821N0393UNIVERSITY OF NEW MEXICO258-NETWORK CNTRCT OFF 22G (36C258)$31,866FY2021
36C25821P0312LANTHEUS MEDICAL IMAGING, INC.258-NETWORK CNTRCT OFF 22G (36C258)$101,384FY2021
36C25821N0382CSL BEHRING L.L.C.258-NETWORK CNTRCT OFF 22G (36C258)$152,276FY2021
36C25821N0375CARDINAL HEALTH 414, LLC258-NETWORK CNTRCT OFF 22G (36C258)$182,654FY2021

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25817J2987_3600_V797P7335A_3600 · retrieved 2026-09-26.